This hypothesis is substantiated by the relatively strong correlation between the decreased total mTOR protein induced by metformin (Fig. 3) and the resultant inhibition of proliferation and migration of breast cancer cells (Fig. 5). This evidence concerns the gene MTOR and breast carcinoma.